The E262K mutation in Lamin A links nuclear proteostasis imbalance to laminopathy-associated premature aging.

Ghosh, Debasish Kumar; Pande, Shruti; Kumar, Jeevan; Yesodharan, Dhanya; Nampoothiri, Sheela; Radhakrishnan, Periyasamy; Reddy, Chilakala Gangi; Ranjan, Akash et al. · Aging Cell · 2022

case_report · Level V

Where this comes from

Abstract

Deleterious, mostly de novo, mutations in the lamin A (LMNA) gene cause spatio-functional nuclear abnormalities that result in several laminopathy-associated progeroid conditions. In this study, exome sequencing in a sixteen-year-old male with manifestations of premature aging led to the identification of a mutation, c.784G>A, in LMNA, resulting in a missense protein variant, p.Glu262Lys (E262K), that aggregates in nucleoplasm. While bioinformatic analyses reveal the instability and pathogenicity of LMNA<sup>E262K</sup> , local unfolding of the mutation-harboring helical region drives the structural collapse of LMNA<sup>E262K</sup> into aggregates. The E262K mutation also disrupts SUMOylation of lysine residues by preventing UBE2I binding to LMNA<sup>E262K</sup> , thereby reducing LMNA<sup>E262K</sup> degradation, aggregated LMNA<sup>E262K</sup> sequesters nuclear chaperones, proteasomal proteins, and DNA repair proteins. Consequently, aggregates of LMNA<sup>E262K</sup> disrupt nuclear proteostasis and DNA repair response. Thus, we report a structure-function association of mutant LMNA<sup>E262K</sup> with toxicity, which is consistent with the concept that loss of nuclear proteostasis causes early aging in laminopathies.

Medical subject headings